Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | PRKDC | P78527 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | EDNRB | P24530 | 1/20 | 0.30 |
| ▸ | EDNRA | P25101 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17875852 | 0.95 | HSP90AA1 (0.32) | ALOX5BACE1KDM4EATML3MBTL1 | |
| SCHEMBL17875817 | 0.95 | HSP90AA1 (0.32) | ALOX5BACE1KDM4EATML3MBTL1 | |
| SCHEMBL17877776 | 0.89 | TNKS (0.33) | PRKDC | |
| SCHEMBL17875775 | 0.89 | ALOX5 (0.32) | ALOX5BACE1KDM4EATML3MBTL1 | |
| SCHEMBL17875908 | 0.88 | ALOX5 (0.40) | ALOX5BACE1KDM4EPRKDCHSP90AA1 | |
| SCHEMBL17875880 | 0.88 | ALOX5 (0.48) | ALOX5KDM4EATML3MBTL1PRKDC | |
| SCHEMBL17876282 | 0.87 | FAAH (0.35) | ALOX5BACE1KDM4EATML3MBTL1 | |
| SCHEMBL17875983 | 0.87 | BACE1 (0.31) | ALOX5BACE1PRKDCEDNRBEDNRA | |
| SCHEMBL17875881 | 0.86 | NPC1 (0.38) | KDM4EATML3MBTL1PRKDCEDNRB | |
| SCHEMBL17875879 | 0.86 | NPC1 (0.35) | KDM4EATML3MBTL1PRKDCHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10581000-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-03-03 | — | — | US | disclosed |
| US-20160190482-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
| US-20160190482-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10581000-B2 | Condensed cyclic compound and organic light-emitting device including the same | CRY1, CRY2, CCNE2 | ALOX5 3059/4885BACE1 709/4885KDM4E 3120/4885 |
| US-20160190482-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | ALOX5 3059/4885BACE1 709/4885KDM4E 3120/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.